Practice Expertise
- Intellectual Property
Areas of Practice
- Intellectual Property
Profile
*This Haynes and Boone professional is not licensed to practice law.
Dr. Mark Moore concentrates his practice in the area of intellectual property law, including the preparation and prosecution of U.S. and foreign patent applications in the biochemical, medical, pharmaceutical, and molecular genetic arts. For the past 25 years, Mark has assisted clients with patent procurement, and has been involved in various aspects of patent portfolio development, including implementation of effective patent prosecution strategies for technologies in the chemical, pharmaceutical and life sciences. He also has significant experience as a technical consultant in various aspects of intellectual property, and has assisted attorneys with due diligence, opinion, expert witness preparation, discovery, and litigation work.
Mark has represented a number of U.S. and foreign clients in the following areas:
Therapeutics and diagnostics in the areas of diabetes, obesity and a variety of neurological, oncological, metabolic, and cardiac diseases
Plant genetics and agricultural products including genetically-modified crops, microbial bioremediation, and environmental methods
Pharmaceutical and nutraceutical compounds, protein and antibody production methods, microarray technologies, and gene therapy methods
Medical devices, implants, optical, ultrasound, CT, electron microscopic and magnetic resonance imaging instrumentation and methods
Before joining Haynes and Boone, Mark spent six years with the Houston IP firm of Williams, Morgan & Amerson, and prior to that, was a patent agent in the Austin office of the former Arnold, White & Durkee for more than five years. Prior to beginning his intellectual property career, Mark was an academic researcher in the field of molecular genetics. His doctoral dissertation focused on molecular aspects of membrane biogenesis in photosynthetic bacteria, and characterization of the phylogenetic relatedness of more than two dozen species of photosynthetic prokaryotes.
Mark is a co-inventor of U.S. and foreign patents involving a variety of technologies, including methods for bioremediation of environmental heavy-metal contaminants; the generation of hydrogen fuel by photosynthetic bacteria; and molecular biological methods for treating human diseases including hypertension.
Dr. Mark Moore concentrates his practice in the area of intellectual property law, including the preparation and prosecution of U.S. and foreign patent applications in the biochemical, medical, pharmaceutical, and molecular genetic arts. For the past 25 years, Mark has assisted clients with patent procurement, and has been involved in various aspects of patent portfolio development, including implementation of effective patent prosecution strategies for technologies in the chemical, pharmaceutical and life sciences. He also has significant experience as a technical consultant in various aspects of intellectual property, and has assisted attorneys with due diligence, opinion, expert witness preparation, discovery, and litigation work.
Mark has represented a number of U.S. and foreign clients in the following areas:
Therapeutics and diagnostics in the areas of diabetes, obesity and a variety of neurological, oncological, metabolic, and cardiac diseases
Plant genetics and agricultural products including genetically-modified crops, microbial bioremediation, and environmental methods
Pharmaceutical and nutraceutical compounds, protein and antibody production methods, microarray technologies, and gene therapy methods
Medical devices, implants, optical, ultrasound, CT, electron microscopic and magnetic resonance imaging instrumentation and methods
Before joining Haynes and Boone, Mark spent six years with the Houston IP firm of Williams, Morgan & Amerson, and prior to that, was a patent agent in the Austin office of the former Arnold, White & Durkee for more than five years. Prior to beginning his intellectual property career, Mark was an academic researcher in the field of molecular genetics. His doctoral dissertation focused on molecular aspects of membrane biogenesis in photosynthetic bacteria, and characterization of the phylogenetic relatedness of more than two dozen species of photosynthetic prokaryotes.
Mark is a co-inventor of U.S. and foreign patents involving a variety of technologies, including methods for bioremediation of environmental heavy-metal contaminants; the generation of hydrogen fuel by photosynthetic bacteria; and molecular biological methods for treating human diseases including hypertension.
Bar Admissions
United States Patent and Trademark Office
Education
- Ph.D., University of Illinois at Urbana-Champaign, 1994
- M.S., University of Illinois at Urbana-Champaign, 1987
- B.S., Texas A&M University, 1984, magna cum laude
Areas of Practice
- Intellectual Property
Meet our Firms and Professionals
WSG’s member firms include legal, investment banking and accounting experts across industries and on a global scale. We invite you to meet our member firms and professionals.
